Skip to main content

Table 1 Pap test coverage

From: Human Papilloma Virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada

Had a test

18–29 years (N = 77)

30–44 years (N = 86)

45–59 years (N = 102)

60–69 years (N = 52)

Total (N = 317)

At some time in their life

68 (65–78)

90 (81–95)

93 (86–97)

92 (81–98)

86 (81–89)

<1 year ago

58 (47–70)

62 (51–72)

53 (43–63)

40 (27–55)

55 (49–60)

1 to 3 years ago

9 (4–18)

15 (8–24)

16 (9–24)

21 (11–35)

15 (11–19)

>3 years ago

0 (0–5)

13 (7–22)

25 (17–34)

31 (12–45)

16 (13–21)

  1. Percentages are presented